Sign In
Buy CNS
$70.20
-1.00 (-1.40%)
At Close: Jun 03, 2026
Cohen & Steers Real Estate Securities Fund Receives LSEG Lipper Performance Award
09:00am, Monday, 24'th Mar 2025
NEW YORK , March 24, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today that the Cohen & Steers Real Estate Securities Fund (CSZIX) has received a 2025 LSEG Lipper Fund Award for i
Corero Network Security Accelerates AI Integration with Focus on Substance Over Hype
07:00am, Thursday, 13'th Mar 2025
MARLBOROUGH, Mass. , March 13, 2025 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the DDoS protection specialists, today announced the strategic advancement of AI capabilities ac
Contineum Therapeutics to Present at the Stifel 2025 Virtual CNS Forum
04:05pm, Wednesday, 12'th Mar 2025
SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of
Xenon to Present at Stifel 2025 Virtual CNS Forum
04:01pm, Wednesday, 12'th Mar 2025
VANCOUVER, British Columbia and BOSTON, March 12, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, develop
Neurocrine Biosciences to Present at the Stifel 2025 Virtual CNS Forum
04:01pm, Tuesday, 11'th Mar 2025
SAN DIEGO , March 11, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the Stifel 2025 Virtual CNS Forum at 1:30 p.m. Eastern Time on Tuesday, March 18, 2025.
Alnylam to Webcast Presentation at Stifel 2025 Virtual CNS Forum
08:00am, Tuesday, 11'th Mar 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Stifel 20
Dyne Therapeutics to Present at Stifel 2025 Virtual CNS Forum
07:30am, Tuesday, 11'th Mar 2025
WALTHAM, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetical
Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum
07:00am, Tuesday, 11'th Mar 2025
WATERTOWN, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of
Cohen & Steers Announces the Retirement of Daniel P. Charles, Head of Global Distribution
04:35pm, Monday, 10'th Mar 2025
NEW YORK , March 10, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today that Daniel P. Charles, Executive Vice President and Head of Global Distribution, will retire after 37 years
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for February 2025
04:24pm, Monday, 10'th Mar 2025
NEW YORK , March 10, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $88.6 billion as of February 28, 2025, an increase of $2.1 billion from
Vistagen to Participate in Stifel 2025 Virtual CNS Forum
08:30am, Tuesday, 04'th Mar 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize
Cohen & Steers Launches SICAV Short Duration Preferred Income Fund
04:00am, Monday, 03'rd Mar 2025
LONDON , March 3, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today the launch of the Cohen & Steers SICAV Short Duration Preferred Income Fund. This is the firm's second fund foc
31 Upcoming Dividend Increases, Including 3 Kings
09:16pm, Thursday, 27'th Feb 2025
This week sees 31 dividend increases, including three Dividend Kings: Genuine Parts, Commerce Bancshares, and Kimberly-Clark, showcasing impressive financial stability and growth. My investment strate
Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
06:34pm, Thursday, 27'th Feb 2025
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the dis
Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)
06:28pm, Thursday, 27'th Feb 2025
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of
